Next, the frequency distribution of PRPF3 CNV patients in different stage and grade groups was presented in Figure 5C, suggesting the high occurrence and an early-event of PRPF3 CNV alteration in HCC. This evidence concerns the gene PRPF3 and hepatocellular carcinoma.